SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-067195
Filing Date
2010-03-25
Accepted
2010-03-25 16:46:50
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q (9/30/2008) d10q.htm 10-Q 952596
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 10074
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 10346
4 CERTIFICATION PERSUANT TO U.S.C. SECTION 1350 dex321.htm EX-32.1 5231
5 CERTIFICATION PERSUANT TO U.S.C. SECTION 1350 dex322.htm EX-32.2 5413
  Complete submission text file 0001193125-10-067195.txt   985038
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-09601 | Film No.: 10704966
SIC: 2834 Pharmaceutical Preparations